NEW APPROACHES FOR ADJUVANT DEVELOPMENT IN PROPHYLACTIC VACCINES

In Prophylactic Vaccines by Freya SmaleLeave a Comment

Dr Agger

NEW APPROACHES FOR ADJUVANT DEVELOPMENT IN PROPHYLACTIC VACCINES

Dr Else Marie Agger, Head of Research, SSI joined us at the World Vaccine Congress Lyon 2012 to lead a discussion into new approaches for adjuvant development in prophylactic vaccines.

Why not download the full presentation and discover more about new approaches for vaccine adjuvants development in prophylactic vaccines. Dr Agger's covered the following discussion points:

  • Overview of adjuvant development
  • Novel two component adjuvants for induction of cell-mediated immune responses
  • Case studies with a focus on preclinical development, manufacturing process and human phase I trials

Download the full presentation here >

For more information about this and other topics discussed at the World Vaccine Congress Lyon, subscribe to the Vaccine Nation newsletter, or visit the event website.

For more updates on the vaccines industry, follow us on Twitter: @vaccinenation or join our LinkedIn group: Vaccine Nation

Leave a Comment

Current ye@r *